Sensorion announces a publication in Hearing Research on kinetics of prestin blood levels after noise trauma-induced hearing loss. pdfRead

Sensorion announces completion of patient enrollment and dosing in Seliforant phase 2a study. pdfRead

Sensorion enters into exclusive negotiations with Pasteur Institute for hearing loss Gene Therapy programs. pdfRead

Sensorion announces presentation of SENS-401 poster at society for Neuroscience 2018 annual meeting. pdfRead

Sensorion Reports Pipeline Update and First-Half-Year 2018 Results. Re-design of SENS-111 Study. pdfRead

Sensorion Reports Pipeline Update and First-Half-Year 2018 Results

Re-design of SENS-111 Study

Pipeline

2018 08 Pipeline

Enregistrer

Patient center

Corporate presentation

Next events